First-pass contrast bolus hemodynamics contain information on right ventricular function, remodeling, and lung resistance in pulmonary arterial hypertension patients 
Purpose
To evaluate first-pass contrast bolus hemodynamic parameters in relation to biventricular function and pulmonary hemodynamics in patients undergoing right heart catheterization (RHC) for known or suspected PAH. For evaluation of bolus hemodynamics, a 1:10 diluted contrast bolus (0.0025ml/min/kg) of gadopentetate dimeglumine was administered intravenously, and a short-axis saturation-recovery GRE slice was acquired in the proximal third of both ventricles over 40 heartbeats with one image per beat. For analysis, two regions of interest were drawn in the right and left ventricular cavities, and timeintensity curves were generated. From these curves, PTT, FWHM, and time-to-peak were calculated (Figure 1) .
Results
Right-to-left-ventricular PTT, LV FWHM, and LV timeto-peak for PAH patients (8.2s, 8.2s, 4.8s) were significantly longer than for non-PAH (6.5s, p=0.006; 5.0s, p=0.01; 3.6s, p=0.01) and control subjects (6.4s, p=0.0003; 5.2s, p=0.0004; 3.2s, p<0.0001) ( Table 1) . There were significant correlations of all three parameters with pulmonary hemodynamics and biventricular function and structure (Table 2 ). In linear regression analysis, including PVRI, ventricular mass index (VMI), and CI as covariates, PTT was predicted by RVCI and VMI, while FWHM and time-to-peak were predicted by PVRI. In receiver operator characteristics (ROC) analysis for transit time to distinguish between PAH patients with and without right heart failure (RVCI <2.2L/min/m 2 ) the area under the ROC curve was 0.82 with a sensitivity of 100% and specificity of 63.6% for a threshold of 8.1s.
Conclusions
While right-to-left-ventricular PTT in PAH patients is mainly predicted by right ventricular cardiac function and biventricular remodeling, time-to-peak and FWHM are associated with pulmonary vascular resistance. Their predictive value regarding patient prognosis warrants further investigation. 0.0001* Peak-to-peak cardiopulmonary transit time, left ventricular full-width-halfmaximum (FWHM) and time-to-peak measurements were significantly longer for PAH patients than for non-PAH patients and healthy controls. 
